These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 7337980

  • 1. Complement-mediated solubilization in patients with systemic lupus erythematosus, nephritis or vasculitis.
    Schifferli JA, Morris SM, Dash A, Peters DK.
    Clin Exp Immunol; 1981 Dec; 46(3):557-64. PubMed ID: 7337980
    [Abstract] [Full Text] [Related]

  • 2. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T, Fujita T, Kono I, Kabashima T, Yamane K, Tamura N, Kashiwagi H.
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [Abstract] [Full Text] [Related]

  • 3. The effect of sera of patients with systemic lupus erythematosus on artificial immune complexes.
    Bányai A, Szabó G, Csongor J, Sonkoly I, Szegedi G.
    Acta Med Hung; 1985 Apr; 42(1-2):51-7. PubMed ID: 4034337
    [Abstract] [Full Text] [Related]

  • 4. [Serum complement levels in patients with rheumatoid arthritis and vasculitis].
    Tomooka K.
    Fukuoka Igaku Zasshi; 1989 Oct; 80(10):456-66. PubMed ID: 2613159
    [Abstract] [Full Text] [Related]

  • 5. Solubilization of immune complexes and inhibition of immune precipitation in SLE sera.
    Balestrieri G, Pagani D, Tincani A.
    J Clin Lab Immunol; 1983 Nov; 12(3):147-50. PubMed ID: 6663608
    [Abstract] [Full Text] [Related]

  • 6. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
    Baatrup G, Jonsson H, Sjöholm A, Sturfelt G, Svehag SE.
    J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
    [Abstract] [Full Text] [Related]

  • 7. Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus.
    Adu D, Williams DG.
    Clin Exp Immunol; 1984 Mar; 55(3):495-501. PubMed ID: 6705265
    [Abstract] [Full Text] [Related]

  • 8. Direct stimulation of neutrophil oxygenation activity by serum from patients with systemic lupus erythematosus: a relationship to disease activity.
    Via CS, Allen RC, Welton RC.
    J Rheumatol; 1984 Dec; 11(6):745-53. PubMed ID: 6520828
    [Abstract] [Full Text] [Related]

  • 9. Terminal complement complex in plasma from patients with systemic lupus erythematosus and other glomerular diseases.
    Horigome I, Seino J, Sudo K, Kinoshita Y, Saito T, Yoshinaga K.
    Clin Exp Immunol; 1987 Nov; 70(2):417-24. PubMed ID: 3427827
    [Abstract] [Full Text] [Related]

  • 10. Reduced complement-mediated immune complex solubilizing capacity and the presence of incompletely solubilized immune complexes in SLE sera.
    Baatrup G, Petersen I, Jensenius JC, Svehag SE.
    Clin Exp Immunol; 1983 Nov; 54(2):439-47. PubMed ID: 6652967
    [Abstract] [Full Text] [Related]

  • 11. Assay, purification and further characterization of 7S C1q-precipitins (C1q-p) in hypocomplementemic vasculitis urticaria syndrome and systemic lupus erythematosus.
    Marder RJ, Potempa LA, Jones JV, Toriumi D, Schmid FR, Gewurz H.
    Acta Pathol Microbiol Immunol Scand Suppl; 1984 Nov; 284():25-34. PubMed ID: 6375256
    [Abstract] [Full Text] [Related]

  • 12. Erythrocyte complement receptor type 1 in patients with systemic lupus erythematosus.
    Yen JH, Liu HW, Lin SF, Chen JR, Chen TP.
    J Rheumatol; 1989 Oct; 16(10):1320-5. PubMed ID: 2810256
    [Abstract] [Full Text] [Related]

  • 13. Mononuclear phagocyte system in SLE. II. A kinetic model of immune complex handling in systemic lupus erythematosus.
    Meryhew NL, Kimberly RP, Messner RP, Runquist OA.
    J Immunol; 1986 Jul 01; 137(1):97-102. PubMed ID: 3486919
    [Abstract] [Full Text] [Related]

  • 14. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
    Sekita K, Doi T, Muso E, Yoshida H, Kanatsu K, Hamashima Y.
    Clin Exp Immunol; 1984 Mar 01; 55(3):487-94. PubMed ID: 6608422
    [Abstract] [Full Text] [Related]

  • 15. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
    Bourke BE, Moss IK, Mumford P, Horsfall A, Maini RN.
    Clin Exp Immunol; 1982 Jun 01; 48(3):726-32. PubMed ID: 6981475
    [Abstract] [Full Text] [Related]

  • 16. Circulating immune complexes in lupus erythematosus, scleroderma and dermatomyositis.
    Sølling J, Sølling K, Jacobsen KU.
    Acta Derm Venereol; 1979 Jun 01; 59(5):421-6. PubMed ID: 93365
    [Abstract] [Full Text] [Related]

  • 17. Solubilization of intraglomerular deposits of IgG immune complexes by human sera or gamma-globulin in patients with lupus nephritis.
    Tomino Y, Sakai H, Takaya M, Miura M, Suga T, Endoh M, Nomoto Y.
    Clin Exp Immunol; 1984 Oct 01; 58(1):42-8. PubMed ID: 6206971
    [Abstract] [Full Text] [Related]

  • 18. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P, Deliyska B, Fünfstück R, Hein G, Herrmann D, Stein G.
    Clin Rheumatol; 2003 Oct 01; 22(4-5):271-8. PubMed ID: 14576989
    [Abstract] [Full Text] [Related]

  • 19. Patients with systemic lupus erythematosus are deficient in complement-dependent prevention of immune precipitation.
    Arason GJ, Steinsson K, Kolka R, Víkingsdóttir T, D'Ambrogio MS, Valdimarsson H.
    Rheumatology (Oxford); 2004 Jun 01; 43(6):783-9. PubMed ID: 15054157
    [Abstract] [Full Text] [Related]

  • 20. Kinetic analysis of immune complex solubilization: complement function in relation to disease activity in SLE.
    Sturfelt G, Nived O, Sjöholm AG.
    Clin Exp Rheumatol; 1992 Jun 01; 10(3):241-7. PubMed ID: 1582069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.